Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Items must be in original packaging with the seal intact
In June 2019, the FDA approved PT-141 under the brand name Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women
It may also benefit individuals with active lifestyles, those looking to support healthy metabolic function, or people interested in maintaining cardiovascular wellness as they age
Current evidence suggests that Allulose has little to no significant impact on fasting blood sugar or insulin levels
For weight management coverage, Blue Cross has added coverage in 2024 for office visits and consultations, labs, and the cost of radiology and complications from bariatric surgery to support members with lifestyle modifications that are key to a weight loss journey
